| Demographic | Parameter | Group (I): N = 175 (76%) | Group (II): N = 55 (24%) | P |
| Age (yrs) | 56 ± 4 | 50 ± 2 | 0.01 | |
| Height (cm) | 170 ± 4 | 167 ± 6 | NS | |
| Weight (kg) | 90 ± 2 | 86 ± 4 | NS | |
| BMI (kg/m2) | 32 ± 2 | 31 ± 3 | NS | |
| Gender male, n (%) | 133 (76%) | 98 (80%) | NS | |
| Medications | ASA, n (%) | 175 (100%) | 55 (100%) | NS |
| Clopidogrel, n (%) | 175 (100%) | 55 (100%) | NS | |
| ACEI, n (%) | 147 (84%) | 46 (85%) | NS | |
| ARB, n (%) | 28 (16%) | 8 (15%) | NS | |
| B-Blockers, n (%) | 155 (89%) | 48 (87%) | NS | |
| CCB, n (%) | 23 (13%) | 7 (14%) | NS | |
| Statin, n (%) | 161 (92%) | 50 (91%) | NS | |
| Diuretics, n (%) | 98 (56%) | 40 (74%) | 0.01 | |
| OAD/Insulin, n (%) | 136 (78%) | 42 (77%) | NS | |
| Need for SK-therapy | 0.00 (0%) | 43 (78%) | 0.01 |